Actilyse is a medicine containing the active ingredient(s) alteplase. On this page you will find out more about Actilyse, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: alteplase
Pack size information
Please select the pack size from the options directly below to view information on the medicine.
Information for medicine and pack size:
Actilyse (1 x 10 mg vial, 1 x 10 mL inert diluent vial), 1 pack
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
Myocardial Infarction: Actilyse is indicated for intravenous use in adults for the lysis of suspected occlusive coronary artery thrombi associated with evolving transmural myocardial infarction. Treatment should be initiated as soon as possible after the onset of symptoms. The treatment can be initiated within 12 hours of symptom onset. Pulmonary Embolism: Actilyse is also indicated in patients with acute massive pulmonary embolism in whom thrombolytic therapy is considered appropriate. Acute Ischaemic Stroke; Actilyse is indicated for thrombolytic treatment of acute ischaemic stroke. Treatment must be started as early as possible within 4.5 hours after onset of stroke symptoms and after exclusion of intracranial haemorrhage by appropriate imaging techniques (e.g. cranial computerised tomography or other diagnostic imaging method sensitive for the presence of haemorrhage). The treatment effect is time-dependent; therefore earlier treatment increases the probability of a favourable outcome.
Table of characteristics
1 vial of 10mg powder: Prescription Only Medicine, or Prescription Animal Remedy
1 vial of 10mL diluent: Not scheduled. Not considered by committee
|Visual appearance||Colourless to pale yellow cake of powder.|
|Dosage Form||Injection, powder for|
|Route of administration||Intravenous|
|Visual appearance||A clear liquid free from particles.|
|Dosage Form||Diluent, not applicable|
|Route of administration||Intravenous|
There is one type of pack available.
Pack type 1
|Storage temperature||Store below 30 degrees Celsius|
|Storage conditions||Protect from Light|
|Life time||2 Years|
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.
Found 2 results
Actilyse Powder for injection - myDr.com.au
Actilyse Powder for injection - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Pulmonary embolism (PE) happens when a blood clot blocks one of the arteries in the lungs. Find out about the causes, diagnosis, treatment and prevention of PE.
Read more on myDr website
Found 0 results